Advertisement

Topics

Latest Urology NewsRSS

10:38 EDT 20th September 2017 | BioPortfolio

OncLive® Presents State of the Science Summit™: Advanced Renal Cell and Bladder Cancer

This State of the Science Summit™ is taking place in partnership with Fox Chase Cancer Center OncLive®, a leading digital provider of resources and information for oncology professionals, announces the latest State of the Science Summit™: Advanced Renal Cell and Bladder Cancer, which will be held at 5:30 p.m. Wednesday, Sept. 27, 2017, at ...

Zavante Therapeutics To Present ZOLYD™ Data From Pivotal ZEUS Study At ID Week 2017

SAN DIEGO, Sept. 20, 2017 /PRNewswire/ -- Zavante Therapeutics, Inc., a biopharmaceutical company focused on developing novel therapies to improve the outcomes of hospitalized patients, and its research collaborators will present eight posters related to investigational antibiotic ZOLYD™ (fosfomycin for injection, also known as ZTI-01), at ID Week 2017 to be held October 4-8, 2017 in San Di...

South Korea Nephrology and Urology Devices Market Outlook to 2023 Incontinence Devices, Lithotripters and Renal Dialysis Equipment [Report Updated: 07082017] Prices from USD $5995

South Korea Nephrology and Urology Devices Market Outlook to 2023 Incontinence Devices, Lithotripters and Renal Dialysis EquipmentSummaryGlobalData's new report, "South Korea Nephrology and Urology Market Outlook to 2023", provides key market data on the South Korea Nephrology and Urology market. The report provides value, in millions of US dollars and volume in units within market categories In...

Global Urinary Catheters Market Research Report Forecast 20172022 [Report Updated: 03072017] Prices from USD $2800

Delivery of the Report will take 4872 hours once order is placed.The Global Urinary Catheters Market Research Report Forecast 20172022 is a valuable source of insightful data for business strategists. It provides the Urinary Catheters industry overview with growth analysis and historical futuristic cost, revenue, demand and supply data as applicable. The research analysts provide an elaborate des...

New Documentary Film Shines Light on Physical and Emotional Impact of COPD

RIDGEFIELD, Conn., Sept. 19, 2017 /PRNewswire/ -- A new documentary film, Clear the Air: Opening Up About COPD, which premiered today online, presents the compelling stories of three people who are living with chronic obstructive pulmonary disease (COPD), a debilitating lung disease that affects more than 15 million Americans and is the third leading cause of death in the United States. ...

Lace Up Those Running Shoes - 11th Annual Zero Prostate Cancer Challenge/Baltimore (ZPCC) Is September 24

OWINGS MILLS, Md., Sept. 19, 2017 /PRNewswire-USNewswire/ -- What do country singer/songwriter Jimmy Charles, pro basketball hall of famer Earl Monroe, pro football hall of famer Leonard "Lenny" Moore, former Baltimore Bullet Phil Chenier, and Olympic runner Sanjay Ayre all have in common? They will all be supporting the 11th annual ZERO Prostate Cancer Challenge/Baltimore, Chesapeake Urology...

New Investigation Advises Doctors to Recommend Cranberry Products as First Line of Defense Against Repeated Urinary Tract Infections (UTIs)

CARVER, Mass., Sept. 19, 2017 /PRNewswire/ -- A thorough review of dozens of studies led scientists to conclude that healthcare professionals should be telling their patients to have cranberry products as a first step in reducing recurrent UTIs. The comprehensive meta-analysis and assessment of human clinical trials, published in the official journal of the American Urological Association, Th...

Prometic Reports Positive Clinical Data from Ongoing PBI-4050 Study in Alström Syndrome Patients

Sustained safety observed over 48 weeks of treatment Beneficial clinical effects in liver sustained over 48 weeks of treatment Positive results support requests for meetings with both FDA and EMA to define the clinical-regulatory pathway for approval of PBI-4050 for the treatment of Alström syndrome LAVAL, QC, Sept. 19, 2017 /PRNewswire/ - Prometic Life Sciences Inc. ...

Avadim Technologies Inc. Announces Partnership With Cardinal Health, Inc.

ASHEVILLE, NC--(Marketwired - September 19, 2017) - Avadim Technologies Inc. ("Avadim"), the Bionome Therapies™ life sciences company, today announced that is has partnered with Cardinal Health (NYSE: CAH), a global leader in healthcare services and products, to provide Avadim's line of topical bionome therapies, Theraworx®, to Cardinal Health's customers. Together, Avadim and Cardinal Health'...

NFL Puts Together Winning Game Plan Against Prostate Cancer

Know Your Stats® campaign enters its ninth season. Pro Football Hall of Famer and cancer survivor leads this year’s campaign. New York, NY (PRWEB) September 18, 2017 Prostate cancer is the second most common cancer in men. On any given Sunday 1 in 7 men watching an NFL game will be diagnosed with this disease, but the odds increase to 1 in 5 if they are African American and 1 in 3 if they ...

The Sales Force of a Leading Urology Devices Supplier Improved Performance with the Help of Quantzig’s Services

Quantzig, a global analytics solutions provider, has announced the completion of their recent sales force analytics study on the medical device industry. The client, a prominent urology devices supplier, wanted to build a strong relationship with their dealers. Quantzig helped the client to connect with the dealers and enhance their sales and product offer...

Camurus Announces That FDA Grants Priority Review of NDA for Weekly and Monthly CAM2038 Buprenorphine Depots for Treatment of Opioid Use Disorder

LUND, Sweden, September 18, 2017 /PRNewswire/ -- The FDA has assigned a PDUFA target date of January 19, 2018   Camurus (NASDAQ STO: CAMX) announces that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for weekly and monthly CAM2038 buprenorphine depots for the treatment of adults with opioid use disorder (OUD) and granted a Priority Review. Th...

Patient-reported outcomes of baricitinib in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment

This study evaluates patient-reported outcomes (PROs) in a double-blind, phase III study of baricitinib as monotherapy or combined with methotrexate (MTX) in patients with active rheumatoid arthritis (RA) with...

Global Guanidine Market Data Survey Report 2025 [Report Updated: 25072017] Prices from USD $1500

SummaryGuanidine is the compound with the formula HNCNH22. It is a colourless solid that dissolves in polar solvents. It is a strong base that is used in the production of plastics and explosives. It is found in urine as a normal product of protein metabolism. Guanidine is the functional group on the side chain of arginine. In this report, the guanidine includes guanidine nitrate, guanidine hydroc...

France Nephrology and Urology Devices Market Outlook to 2023 Incontinence Devices, Lithotripters and Renal Dialysis Equipment [Report Updated: 07082017] Prices from USD $5995

France Nephrology and Urology Devices Market Outlook to 2023 Incontinence Devices, Lithotripters and Renal Dialysis EquipmentSummaryGlobalData's new report, "France Nephrology and Urology Market Outlook to 2023", provides key market data on the France Nephrology and Urology market. The report provides value, in millions of US dollars and volume in units within market categories Incontinence Devi...

What Men Should Know About Prostate Cancer, and How Chesapeake Urology is Fighting for a Cure

OWINGS MILLS, Md., Sept. 15, 2017 /PRNewswire-USNewswire/ -- September is National Prostate Cancer Awareness Month and Chesapeake Urology is urging men to take charge of their prostate health this month, and throughout the year. Chesapeake Urology is committed to finding a cure for this disease. In fact, for more than a decade, Chesapeake Urology's signature cause has been ending prostate can...

Tonix Pharma Receives European Patent For The Active Ingredient In Tonmya (Cyclobenzaprine HCL Sublingual Tablets)

  Life Sciences Jobs   ...

Japan Nephrology and Urology Devices Market Outlook to 2023 Incontinence Devices, Lithotripters and Renal Dialysis Equipment [Report Updated: 07082017] Prices from USD $5995

Japan Nephrology and Urology Devices Market Outlook to 2023 Incontinence Devices, Lithotripters and Renal Dialysis EquipmentSummaryGlobalData's new report, "Japan Nephrology and Urology Market Outlook to 2023", provides key market data on the Japan Nephrology and Urology market. The report provides value, in millions of US dollars and volume in units within market categories Incontinence Devices...

BPA Linked to Obesity Risk in Puberty-Age Girls

OAKLAND, Calif., June 12, 2013 /PRNewswire/ -- Girls between 9 and 12 years of age with higher-than-average levels of bisphenol-A in their urine had double the risk of being obese than girls with lower levels of BPA, according to a Kaiser Permanente study published today in the journal PLOS ONE. "This study provides evidence from a human population that confirms the findings from animal studies&#...

Sperm Epigenetics May Be Skewed by Dad’s Exposure to Plastics

Chemicals found in plastics and personal-care products like shaving cream have been known to alter men’s hormone levels and diminish semen quality. Now these chemicals, additives called phthalates, have been found to modify sperm epigenetics. Specifically, phthalates have been linked with altered DNA methylation patterns. Although the phthalate-induced epigenetic changes don’t disrupt DNA ...

GenomeDx to Distribute Pathnostics' Guidance UGx Test for Urinary Tract Infection and Guidance PRx Test for Prostatitis

SAN DIEGO and IRVINE, Calif., Sept. 14, 2017 /PRNewswire/ -- GenomeDx Biosciences, a leader in the field of urologic genomics, and Pathnostics, a provider of comprehensive and dynamic pathology services, today announced a strategic agreement for GenomeDx's distribution of Pathnostics' Guidance UGx and Guidance PRx. These molecular diagnostic tests for urinary tract infections (UTIs) and prost...

United States Incontinence Devices Market Outlook to 2023 [Report Updated: 01082017] Prices from USD $4995

United States Incontinence Devices Market Outlook to 2023SummaryGlobalData's new report, "United States Incontinence Devices Market Outlook to 2023", provides key market data on the United States Incontinence Devices market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segments Protective Garments for Incontinence, Urinary Catheters an...

Tonix Pharmaceuticals Receives European Patent for the Active Ingredient in Tonmya® (Cyclobenzaprine HCl Sublingual Tablets)

NEW YORK, Sept. 14, 2017 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), a company developing innovative pharmaceutical and biological products to address major public health challenges, today announced that Tonix has received a European patent (Patent No. 2501234, “Methods and Compositions for Treating Symptoms Associated with Posttraumatic Stress Disorders U...

Synthon says EPO appeal board has revoked Copaxone API patent

Synthon BV says a Teva patent covering the active ingredient in Copaxone has been revoked by the European Patent Office’s technical board of appeal.

NFL and Urology Care Foundation Team Up to Raise Prostate Cancer Awareness

BALTIMORE, Sept. 13, 2017 /PRNewswire-USNewswire/ -- September is National Prostate Cancer Awareness Month, the start of football season and the time of year when the National Football League (NFL) and Urology Care Foundation renew their commitment to educate men about their prostate health through the Know Your Stats About Prostate Cancer® campaign.  The Know Your Stats® campaign aim...

Quick Search
Advertisement
 

review and buy Urology market research data and corporate reports here